ASPIVIX, an innovator in gynaecological and fertility solutions, and Tia: Women’s Health Clinic, the modern medical home for women, are redefining the way women experience gynaecological care across the United States.
Together, ASPIVIX and Tia will expand access to enhanced IUD procedures and improve experience for women in 9 Tia clinics in Los Angeles, New York, San Francisco and Scottsdale across 3 states. The two healthcare trailblazers share the same mission: to put women first by delivering the care each woman needs and deserves through a people-centred approach. This partnership represents a critical step in that mission, setting new standards in the field of gynaecology.
Read more: Aspivix announces MHRA approval for Carevix device
This collaboration will provide comprehensive care and improve patient experiences by offering Carevix, the advanced, pain-reducing solution for women undergoing IUD insertions, for the first time in the US.
This partnership marks ASPIVIX’s further expansion into the U.S. market, following FDA approval of Carevix and positive clinical data presented at ACOG 2024.
Moving away from the use of the traumatic cervical tenaculum, Carevix is designed to redefine the standards of care in gynaecology, offering a more comfortable and empowering experience for patients and healthcare providers alike for transcervical procedures in gynaecology.
You can hear Ikram Guerd, General Manager & VP Global Marketing at Aspivix talk about the Carevix device on an episode of the MedTalk Podcast.
